---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-052539"
form_type: "8-K"
ticker: "FHTX"
cik: "0001822462"
company_name: "Foghorn Therapeutics Inc."
filed_at: "2024-12-30T23:59:59+00:00"
generated_at: "2026-05-28T22:50:43.794039+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Adam M. Koppel resigns from Foghorn Therapeutics board

## Summary
- Adam M. Koppel, M.D., Ph.D., resigned from the Board effective December 29, 2024.
- Resignation not due to any disagreement with the Company or Board.
- Koppel served on the Audit Committee and Nominating and Corporate Governance Committee.
- He was a Class II director with a term expiring at the 2025 Annual Meeting.

## SEC filing metadata
- accession: 0001628280-24-052539
- form_type: 8-K
- ticker: FHTX
- cik: 0001822462
- company_name: Foghorn Therapeutics Inc.
- filed_at: 2024-12-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822462/000162828024052539/0001628280-24-052539-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822462/000162828024052539/fhtx-20241229.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-052539
- JSON: https://secwatch.observer/filing/0001628280-24-052539.json
- Plain text: https://secwatch.observer/filing/0001628280-24-052539.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.